Clin2
NCT07007078Possibly a fitRecruiting

Dihydroartemisinin for acne vulgaris

Acne Vulgaris

Treatments studied

Part of Skin clinical trials.

This study tests if a medicine called dihydroartemisinin (a type of artemisinin, often used for malaria) can help treat acne when applied to the skin. It's a small early-phase trial for people with acne vulgaris.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
60 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You have been diagnosed with common acne (acne vulgaris).
  • If you are a woman of childbearing age, you must not be planning to become pregnant in the next 6 months.
  • You have not taken any oral acne medication or hormone treatments in the last 3 months.
  • You have not used any acne creams or gels in the last 2 weeks.
  • You are not pregnant or breastfeeding.
  • You do not have a serious heart, liver, kidney disease, or cancer.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07449156Not yet recruiting· Phase 1/Phase 2
New medication for facial acne

This study tests a new medication called HB0043 for people with mild to moderate facial acne. It aims to see if the treatment is safe and effective in reducing acne.

Jinan, Shandong
NCT07421804Not yet recruiting
Dutasteride gel for facial acne versus standard combination gel

This study tests a new acne gel made from dutasteride (a medication often used for hair loss) against a standard three-ingredient prescription gel. It aims to see if the dutasteride gel is safe and works well for treating facial acne.

NCT07866105Not yet recruiting· Phase 2
Acne spray study for teens and adults

This trial is testing a new spray called B244 that you put on your face to help treat moderate to severe acne. It aims to see if it is safe, works well, and is comfortable to use.

NCT06905210Recruiting· Phase 3
New hormonal pill for moderate acne in women

This trial tests a new combination hormonal pill (a progestogen and low-dose estrogen) to treat moderate acne in women. It may be an option if you have not had success with other acne treatments.

Itapevi, São Paulo
NCT03883269Recruiting· Phase 4
Tests topical antibiotics’ anti-inflammatory effect in acne

This trial studies whether putting antibiotic creams on mild-to-moderate facial acne reduces inflammation. It may help answer whether topical erythromycin or clindamycin can improve acne-related redness and swelling.

Leiden
NCT07012486Recruiting· Early Phase 1
Dihydroartemisinin for female hair loss

This trial tests if dihydroartemisinin, a medicine derived from a plant, can help treat female pattern hair loss. It may be an option for women who haven't used other hair loss treatments recently.

Shanghai, Shanghai Municipality

Hear when a new Acne Vulgaris trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.